Tubulis Technologies raised €60M in a Series B round in May 2022. The company is based in Munich, Germany. Investors in the round: Andera Partners, Bayern Kapital, BioMedPartners and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €60M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
